Fatal events in cancer patients receiving anticoagulant therapy for venous thromboembolism

Medicine (United States)

Volumn 94, Issue 32, 2015, Pages

  Farge, Dominique ^a   Trujillo Santos, Javier ^b   Debourdeau, Philippe ^c   Bura Riviere, Alessandra ^d   Rodriguez Beltrán, Eva Maria ^e   Nieto, Jose Antonio ^f   Peris, Maria Luisa ^g   Zeltser, David ^h   Mazzolai, Lucia ⁱ   Hij, Adrian ^a   Monreal, Manuel ^j   Durante, Alessandro ^k   Alcalde, M ^k   Arcelus, J I ^k   Ballaz, A ^k   Barba, R ^k   Barron, M ^k   Barron Andres B ^k   Bascunana, J ^k   Bedate, P ^k   Blanco Molina, A ^k   Bueso, T ^k   Casado, I ^k   Conget, F ^k   Del Molino, F ^k   Del Toro, J ^k   Falga C ^k   Fernandez Capitan C ^k   Fuentes, M I ^k   Gallego, P ^k   Garcia J ^k   Garcia Bragado F ^k   Gavin O ^k   Gomez, V ^k   Gonzalez, J ^k   Gonzalez Bachs E ^k   Grau, E ^k   Guil, M ^k   Guijarro, R ^k   Gutierrez, J ^k   Hernandez, L ^k   Jara Palomares, L ^k   Jaras, M J ^k   Jimenez, D ^k   Jimenez, S ^k   Lobo, J L ^k   Lopez Jimenez L ^k   Lopez Saez J B ^k   Lorente, M A ^k   Lorenzo, A ^k   Luque, J M ^k   Madridano, O ^k   Macia M ^k   Maestre, A ^k   Marchena, P J ^k   Martin M ^k   Monreal, M ^k   Mora, J M ^k   Munoz, F J ^k   Nauffal, M D ^k   Nieto, J A ^k   Nunez M J ^k   Ogea, J L ^k   Otero, R ^k   Pedrajas, J M ^k   Peris, M L ^k   Riera Mestre, A ^k   Rivas, A ^k   Rodriguez Davila M A ^k   Roman, P ^k   Rosa, V ^k   Ruiz, J ^k   Ruiz Ribo M D ^k   Ruiz Gamietea, A ^k   Ruiz Gimenez N ^k   Sahuquillo, J C ^k   Samperiz, A ^k   Sanchez Munoz Torrero J F ^k   Soler, S ^k   Tiberio, G ^k   Tilvan, R M ^k   Tolosa, C ^k   Trujillo, J ^k   Uresandi, F ^k   Valdes M ^k   Valero, B ^k   Valle, R ^k   Vela, J ^k   Vidal, G ^k   Villalobos, A ^k   Villalta, J ^k   Gadelha, T ^k   Maly, R ^k   Hirmerova, J ^k   Tomko, T ^k   Bertoletti, L ^k   Bura Riviere, A ^k   Farge Bancel, D ^k   Grange, C ^k   Hij, A ^k   Mahe, I ^k   Merah, A ^k   Quere, I ^k   Schellong, S ^k   Babalis, D ^k   Papadakis, M ^k   Tzinieris, I ^k   Faul, J ^k   Braester, A ^k   Brenner, B ^k   Tzoran, I ^k   Zeltser, D ^k   Barillari, G ^k   Ciammaichella, M ^k   Dalla Valle, F ^k   Di Micco, P ^k   Duce, R ^k   Maida, R ^k   Pasca, S ^k   Piovella, C ^k   Poggio, R ^k   Prandoni, P ^k   Quintavalla, R ^k   Rocci, A ^k   Rota, L ^k   Schenone, A ^k   Tiraferri, E ^k   Tonello, D ^k   Tufano, A ^k   Visona A ^k   Zalunardo, B ^k   Brinquinho, M ^k   Gomes, D ^k   Goncalves F ^k   Santos, M ^k   Saraiva, M ^k   Bosevski, M ^k   Kovacevic, D ^k   Alatri, A ^k   Aujeski, D ^k   Bounameaux, H ^k   Calanca, L ^k   Mazzolai, L ^k   Caprini, J ^k   more..

^a SAINT LOUIS HOSPITAL   (France)

^b Department of Medical Physics Hospital Universitario Santa Lucia   (Spain)

^c INSTITUT SAINTE CATHERINE   (France)

^d CHU RANGUEIL   (France)

^e Hospital Ntra   (Spain)

^f HOSPITAL VIRGEN DE LA LUZ   (Spain)

^g Instituto Oncológico Consorcio Hospitalario Provincial de Castellón   (Spain)

^h TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

ⁱ LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^j HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^k NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; FIBRINOLYTIC AGENT; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BODY WEIGHT; CANCER PATIENT; COHORT ANALYSIS; DEEP VEIN THROMBOSIS; DISSEMINATED CANCER; FATALITY; FEMALE; FOLLOW UP; HUMAN; LUNG CANCER; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; TREATMENT DURATION; UTERUS CANCER; VENOUS THROMBOEMBOLISM; CLINICAL TRIAL; GASTROINTESTINAL HEMORRHAGE; HEMORRHAGE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NEOPLASM; PROSPECTIVE STUDY; PULMONARY EMBOLISM; VENOUS THROMBOSIS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; COHORT STUDIES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; PULMONARY EMBOLISM; RECURRENCE; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS;

EID: 84942424322     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001235     Document Type: Article

References (24)

1. Prandoni P, Lensing AW, Cogo A, et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996; 125: 1-7.
2. Levitan N, Dowlati A, Remick SC, et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data. Medicine (Baltimore). 1999; 78: 285-291.
3. Monreal M, Falgá C, Valdés M, et al. Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: findings from the RIETE Registry. J Thromb Haemost. 2006; 4: 1950-1956.
4. Lee AY, Peterson EA. Treatment of cancer-associated thrombosis. Blood. 2013; 122: 2310-2317.
5. Wagman LD, Baird MF, Bennett CL, et al. Venous thromboembolic disease. NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2008; 6: 716-753.
6. Meyer G, Marjanovic Z, Valcke J, et al. Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer. Arch Intern Med. 2002; 162: 1729-1735.
7. Lee AYY, Levine MN, Baker RI, et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med. 2003; 34: 146-153.
8. Hull RD, Pineo GF, Brant RF, et al. Long-term low-molecular-weight heparin versus usual care in proximal-vein thrombosis patients with cancer. Am J Med. 2006; 119: 1062-1072.
9. Akl EA, Vasireddi SR, Gunukula S, et al. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer (Review). Cochrane Database Syst Rev. 2011; 15: CD006649.
10. Mandala M, Falanga A, Roila F. Management of venous throm-boembolism (VTE) in cancer patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2011; 22: 85-92.
11. Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease. Antithrombotic therapy and prevention of thrombosis. American College of Chest Physicians evidence-based clinical practice guidelines (9th Edition). Chest. 2012; 141(2 Suppl): e419S-e494S doi: 10.1378/chest.11-2301.
12. Farge D, Debourdeau P, Beckers M, et al. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer. J Thromb Haemost. 2013; 11: 56-70.
13. Debourdeau P, Farge D, Beckers M, et al. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. J Thromb Haemost. 2013; 11: 71-80.
14. Lyman GH, Khorana AA, Kuderer NM, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer. American Society of Clinical Oncology Clinical Practice Guideline Update. J Clin Oncol. 2013; 31: 2189-2204.
15. Carrier M, Le Gal G, Wells PS, et al. Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Ann Intern Med. 2010; 152: 578-589.
16. Laporte S, Mismetti P, Décousus H, et al. Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous throm-boembolism; Findings from the Registro Informatizado de la Enfermedad TromboEmbólica venosa (RIETE) Registry. Circulation. 2008; 117: 1711-1716.
17. Trujillo-Santos, Nieto JA, Tiberio G, et al. Predicting recurrences or major bleeding in cancer patients with venous thromboembolism. Findings from the RIETE Registry. J Thromb Haemost. 2008; 100: 435-439.
18. Gussoni G, Frasson S, La Regina M, et al. Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry. Thromb Res. 2013; 131: 24-30.
19. Montreal M, Falga C, Valdes M, et al. Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism; findings from the RIETE registry. J Thromb Hemost. 2006; 4: 1950-1956.
20. Lecumberri R, Alfonso A, Jiménez D, et al. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism. J Thromb Haemost. 2013; 110: 834-843.
21. Sánchez Muñoz-Torrero JF, Bounameaux H, Pedrajas JM, et al. Effects of age on the risk of dying from pulmonary embolism or bleeding during treatment of deep vein thrombosis. J Vasc Surg. 2011; 54: 26S-32S.
22. Monreal M, Falgá C, Valle R, et al. Venous thromboembolism in patients with renal insufficiency: findings from the RIETE Registry. Am J Med. 2006; 119: 1073-1079.
23. Muriel A, Jiménez D, Aujesky D, et al. Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk. J Am Coll Cardiol. 2014; 63: 1675-1683.
24. Kleinjan A, Aggarwal A, Van de Geer A, et al. A worldwide survey to assess the current approach to the treatment of patients with cancer and venous thromboembolism. J Thromb Haemost. 2013; 110: 959-965.